Marshall Wace’s Blueprint Medicines BPMC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-31,900	Closed	-$4.09M	–	2915
2025 Q2	$4.09M	Buy	31,900 +21,300	+201%	+$2.21M	﹤0.01%	1242
2025 Q1	$938K	Sell	10,600 -151,282	-93%	-$14.8M	﹤0.01%	1809
2024 Q4	$14.1M	Sell	161,882 -171,885	-51%	-$15.7M	0.02%	667
2024 Q3	$30.9M	Sell	333,767 -17,989	-5%	-$1.79M	0.04%	383
2024 Q2	$37.9M	Buy	351,756 +121,464	+53%	+$12.2M	0.05%	321
2024 Q1	$21.8M	Buy	+230,292	New	+$19.8M	0.04%	483
2023 Q1	–	Sell	-529,456	Closed	-$23.2M	–	2692
2022 Q4	$23.2M	Buy	+529,456	New	+$25.4M	0.06%	402
2022 Q2	–	Sell	-186,600	Closed	-$11.9M	–	3457
2022 Q1	$11.9M	Sell	186,600 -764,082	-80%	-$54.8M	0.02%	765
2021 Q4	$102M	Buy	950,682 +923,577	+3,407%	+$96.6M	0.2%	99
2021 Q3	$2.79M	Sell	27,105 -11,981	-31%	-$1.12M	0.01%	1313
2021 Q2	$3.44M	Buy	+39,086	New	+$3.58M	0.02%	1058
2021 Q1	–	Sell	-3,642	Closed	-$408K	–	2494
2020 Q4	$408K	Sell	3,642 -257,260	-99%	-$27.1M	﹤0.01%	1556
2020 Q3	$24.2M	Buy	260,902 +238,042	+1,041%	+$18.3M	0.18%	137
2020 Q2	$1.78M	Sell	22,860 -188,146	-89%	-$12.7M	0.01%	830
2020 Q1	$12.3M	Buy	211,006 +204,103	+2,957%	+$13.1M	0.13%	175
2019 Q4	$553K	Buy	+6,903	New	+$517K	﹤0.01%	1137
2019 Q1	–	Sell	-8,635	Closed	-$466K	–	1723
2018 Q4	$466K	Sell	8,635 -139,699	-94%	-$8.49M	﹤0.01%	1123
2018 Q3	$11.6M	Buy	+148,334	New	+$10.3M	0.1%	275
2017 Q1	–	Sell	-30,302	Closed	-$850K	–	355
2016 Q4	$850K	Buy	+30,302	New	+$913K	0.01%	775

Other funds holding BPMC